1887

Abstract

Intravenous inoculation of an attenuated agerminative strain of (PCA-2) of low virulence, but not of two other species of of low virulence ( and ) into CD2F1 mice conferred protection against the highly virulent microbes CA-6, and To provide protection, a definite inoculum size (10 cells per mouse) resulting in organ colonization and establishment of a long-lasting chronic infection with PCA-2 was needed. An inoculum of 10 cells gave rise to transient kidney colonization whereas inocula greater than 10 cells led to acute septicaemia and eventual death. Chronic infection of mice following inoculation of 10 PCA-2 cells was accompanied by detectable mannoprotein antigen levels in the serum (30–70 ng ml) while specific antibodies did not appear until 14 d after inoculation, at which time low antimannan antibody was present (ELISA titre 1:40–1:80). Chronic infection was characterized by the presence in the kidneys of 2–3 × 10 c.f.u. of PCA-2 for at least 40 d after inoculation. Pharmacological modulation of the host through administration of either an anti- drug, amphotericin B, or an immunosuppressive agent, cyclophosphamide, strongly supported the premise that the anti-infectious state conferred by PCA-2 ‘immunization’ correlated with the maintenance of a sufficient number of PCA-2 Protection was ‘switched on’ when 2–3 × 10 cells were present in the kidneys. It was maximal at a kidney count of 2–3 × 10 c.f.u. of PCA-2, and promptly declined when the number of PCA-2 cells in the kidneys fell below 2 × 10. Mice chronically infected with PCA-2 had splenic macrophages with pronounced candidacidal activity Modulation of the growth of PCA-2 , which determined activation or deactivation of the protective state, was paralleled by a similar modulation in macrophage activation, showing that in all cases resistance to virulent organisms persisted as long as macrophage activation was present. The results demonstrate that a critical antigenic load is crucial for the occurrence of resistance to infection and suggests that macrophages could be involved in this protection.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-134-9-2583
1988-09-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/micro/134/9/mic-134-9-2583.html?itemId=/content/journal/micro/10.1099/00221287-134-9-2583&mimeType=html&fmt=ahah

References

  1. Ausiello C.M., Spagnoli G.C., Boccanera M., Casalinuovo I., Malavasi F., Casciani C.U., Cassone A. 1986; Proliferation of human PBL induced by Candida albicans and its cell wall fractions.. Journal of Medical Microbiology 22:195–202
    [Google Scholar]
  2. Baccarini M., Bistoni F., Puccetti P., Garaci E. 1983; a. Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide: nature of the in vitro cytotoxic effector.. Infection and Immunity 42:1–9
    [Google Scholar]
  3. Baccarini M., Blasi E., Puccetti P., Bistoni F. 1983; b. Phagocytic killing of Candida albicans by different murine effector cells.. Sabouraudia 21:271–286
    [Google Scholar]
  4. Bistoni F., Baccarini M., Blasi E., Puccetti P., Marconi P. 1982; A radiolabel release microassay for phagocytic killing of Candida albicans.. Journal of Immunological Methods 52:369–377
    [Google Scholar]
  5. Bistoni F., Baccarini M., Blasi E., Marconi P., Puccetti P., Garaci E. 1983; Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice.. Infection and Immunity 40:46–55
    [Google Scholar]
  6. Bistoni F., Vecchiarelli A., Cenci E., Sbaraglia G., Perito S., Cassone A. 1984; A comparison of experimental pathogenicity of Candida species in cyclophosphamide-immunodepressed mice.. Sabouraudia 22:409–418
    [Google Scholar]
  7. Bistoni F., Vecchiarelli A., Mazzolla R., Puccetti P., Marconi P., Garaci E. 1985; Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans.. Antimicrobial Agents and Chemotherapy 27:625–631
    [Google Scholar]
  8. Bistoni F., Vecchiarelli A., Cenci E., Puccetti P., Marconi P., Cassone A. 1986; Evidence for macrophage mediated protection against lethal Candida albicans infection.. Infection and Immunity 51:668–674
    [Google Scholar]
  9. Cockayne A., Odds F.C. 1984; Interactions of Candida albicans yeast cells, germ-tubes and hyphae with human polymorphonuclear leucocytes in vitro.. Journal of General Microbiology 130:465–471
    [Google Scholar]
  10. Gooday G.W. 1986; Chitin estimation to measure fungal biomass.. In Chitin in Nature and Technology pp. 93–98 Muzzarelli R., Jennieux C., Gooday G. W. Edited by New York & London: Plenum Press;
    [Google Scholar]
  11. Herberman R.B., Ortaldo J.R. 1981; Natural killer cells: their role in defense against disease.. Science 214:24–30
    [Google Scholar]
  12. Hurtrel B., Lagrange P.H., Michel J.C. 1980; Systemic candidiasis in mice. II. Main role of polymorphonuclear leukocytes in resistance to infection.. Annales d’immunologie 131:105–118
    [Google Scholar]
  13. Jones J.M. 1980; Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans.. Infection and Immunity 30:78–89
    [Google Scholar]
  14. Mattia E., Carruba G., Angiolella L., Cassone A. 1982; Induction of germ-tube formation by N-acetyl-d-glucosamine in Candida albicans: uptake of inducer and germinative response.. Journal of Bacteriology 152:555–562
    [Google Scholar]
  15. Moser S.A., Domer J.E. 1980; Effect of cyclophosphamide on murine candidiasis.. Infection and Immunity 27:376–386
    [Google Scholar]
  16. Odds F.C. 1979 Candida and Candidosis pp. Leicester, UK:: Leicester University Press.;
    [Google Scholar]
  17. Sasada M., Johnston R.B. 1980; Macrophage microbicidal activity.Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages.. Journal of Experimental Medicine 152:85–98
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-134-9-2583
Loading
/content/journal/micro/10.1099/00221287-134-9-2583
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error